KUALA LUMPUR: Malaysia's health ministry will continue to use hydroxychloroquine in trials to treat COVID-19 patients, said its director-general Noor Hisham Abdullah on Tuesday , adding that authorities will closely monitor any side effects.
The anti-malaria drug is known to cause several side effects such as irregular heartbeat and blurred vision. The World Health Organization said on Monday that it is suspending testing the drug in COVID-19 patients due to safety concerns.“As you may know, it has side effects, which vary from person to person, so there needs to be close monitoring by doctors,” Dr Noor Hisham told reporters at a media conference.
"For example, if a patient has rapid heartbeat, then we will immediately stop usage of the drug in order to prevent heart failure and so on." Dr Noor Hisham said hydroxychloroquine is being used to prevent the coronavirus infection from becoming worse at an early stage.He added that healthcare experts are gathering data, to determine if the use of the drug has been effective.
"The experts are still studying how to prevent existing side effects and avoid high dosage. Let us wait for the literature review which will be issued by the World Health Organization in mid-June," he said.
good if it works perhaps Msia can share with the world...
The WHO 's dismissal of the drug was purely political, totally irresponsible of DrTedros .
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »